Kristin Cahill, global CEO of GCI Group, shared her insights on the evolving challenges facing healthcare communicators. Cahill discussed how polarization and misinformation are reshaping the way pharma and biotech companies must approach stakeholder engagement. She emphasized the need for nuanced, localized communications strategies that can reach diverse audiences without a “one size fits all” approach—especially as traditional media credibility erodes and disinformation becomes a pressing public health threat.
Cahill also revealed how GCI Health is helping clients navigate this complex environment through new tools designed to detect and prioritize disinformation, and by tapping credible third-party advocates to speak authentically. She urged companies to rethink outdated communication models and embrace technology, like AI and real-time data, to keep pace with rapidly shifting public sentiment. For a deeper look at how GCI Health is leading these changes and what’s next for health comms, watch the full interview.
Learn more about GCI Health.